| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.035 | 0.4 |